Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
Status:
Recruiting
Trial end date:
2023-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the safety and duration of effect of 40 Units of
prabotulinumtoxinA-xvfs (Jeuveau®) in providing temporary improvement in the appearance of
moderate to severe glabellar lines (frown lines, which are the vertical lines that develop
between the eyebrows) in adult participants. It will also determine if the duration of effect
of 40 Units of Jeuveau® is greater than that of 20 Units of Jeuveau® and 20 Units of Botox®
Cosmetic.